# Hepion Pharmaceuticals, Inc. (HEPA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HEPA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -2.06M | $ -815.4K | $ 0 | $ 1.28M |
| 2025 | $ 0 | $ -8.48M | $ -3.35M | $ 54.1K | $ 2.67M |
| 2024 | $ 0 | $ -13.87M | $ -19.15M | $ 2.90M | $ -1.86M |
| 2023 | $ 0 | $ -52.90M | $ -44.23M | $ 209.0K | $ 7.28M |
| 2022 | $ 0 | $ -47.14M | $ -39.07M | $ 53.6K | $ 49.86M |
| 2021 | $ 0 | $ -38.91M | $ -37.27M | $ 317.0K | $ 93.00M |
| 2020 | $ 0 | $ -25.93M | $ -20.71M | $ 752.2K | $ 40.52M |
| 2019 | $ 0 | $ -8.67M | $ -9.83M | $ 807.4K | $ 15.62M |
| 2018 | $ 0 | $ -12.48M | $ -20.66M | $ 1.44M | $ 1.98M |
| 2017 | $ 0 | $ -17.62M | $ -19.98M | N/A | $ 3.70M |
| 2016 | $ 0 | $ -25.38M | $ -24.77M | N/A | $ 5.88M |
| 2015 | $ 0 | $ -24.78M | $ -21.79M | N/A | $ 4.98M |
| 2014 | $ 0 | $ -13.43M | $ -5.05M | N/A | $ 8.60M |
| 2013 | $ 0 | $ -498.1K | $ -474.2K | $ 354.9K | $ -489.9K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.51 |
| Current Ratio | 3.91 |

## Other views

- [Metrics](https://sponda.capital/en/HEPA.md)
- [Charts](https://sponda.capital/en/HEPA/charts.md)
- [Compare](https://sponda.capital/en/HEPA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.